Mannkind reported $280.73M in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 124.48M 1.06M
Adma Biologics ADMA:US $ 94.36M 0.49M
Chemocentryx CCXI:US $ 9.56M 2.01M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Flexion Therapeutics FLXN:US $ 250.5M 30.48M
Halozyme Therapeutics HALO:US $ 786.45M 0.88M
Insmed INSM:US $ 571.41M 8.55M
JAZZ PHA JAZZ:US $ 6253.65M 241.68M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Kindred Biosciences KIN:US $ 15.35M 1.58M
Macrogenics MGNX:US $ 0 0
Mannkind MNKD:US $ 280.73M 0.47M
Minerva Neurosciences NERV:US $ 0M 0M
Novavax NVAX:US $ 323.1M 8.84M
Novo Nordisk A Fs NVO:US $ 12398M 65M
Peregrine Pharmaceuticals PPHM:US $ 141.33M 2.52M
Xencor XNCR:US $ 0M 0M